Trade Merck KGaA - EUR - MRKd CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.35 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.01796% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 125.45 |
| Open | 124.55 |
| 1-Year Change | -21% |
| Day's Range | 121.65 - 126.25 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 2, 2025 | 125.45 | 0.15 | 0.12% | 125.30 | 125.65 | 122.95 |
| Apr 1, 2025 | 127.10 | -0.45 | -0.35% | 127.55 | 128.75 | 126.30 |
| Mar 31, 2025 | 126.55 | -2.25 | -1.75% | 128.80 | 129.10 | 126.15 |
| Mar 28, 2025 | 130.40 | 2.40 | 1.88% | 128.00 | 131.10 | 128.00 |
| Mar 27, 2025 | 129.35 | 3.75 | 2.99% | 125.60 | 129.35 | 125.60 |
| Mar 26, 2025 | 127.00 | -3.45 | -2.64% | 130.45 | 131.20 | 126.70 |
| Mar 25, 2025 | 131.00 | 0.95 | 0.73% | 130.05 | 131.70 | 130.00 |
| Mar 24, 2025 | 130.55 | -1.05 | -0.80% | 131.60 | 131.95 | 129.90 |
| Mar 21, 2025 | 131.55 | 0.00 | 0.00% | 131.55 | 131.80 | 130.35 |
| Mar 20, 2025 | 131.85 | -1.95 | -1.46% | 133.80 | 134.40 | 130.30 |
| Mar 19, 2025 | 134.25 | 0.10 | 0.07% | 134.15 | 136.05 | 134.00 |
| Mar 18, 2025 | 135.05 | 1.05 | 0.78% | 134.00 | 137.30 | 134.00 |
| Mar 17, 2025 | 135.45 | 1.80 | 1.35% | 133.65 | 136.15 | 133.65 |
| Mar 14, 2025 | 134.10 | 0.25 | 0.19% | 133.85 | 135.05 | 133.35 |
| Mar 13, 2025 | 134.20 | 0.60 | 0.45% | 133.60 | 134.60 | 132.95 |
| Mar 12, 2025 | 134.35 | 0.35 | 0.26% | 134.00 | 135.45 | 131.40 |
| Mar 11, 2025 | 133.85 | 0.10 | 0.07% | 133.75 | 136.30 | 133.05 |
| Mar 10, 2025 | 133.60 | -2.95 | -2.16% | 136.55 | 137.05 | 132.80 |
| Mar 7, 2025 | 135.95 | -5.95 | -4.19% | 141.90 | 142.10 | 134.40 |
| Mar 6, 2025 | 141.70 | 6.05 | 4.46% | 135.65 | 142.20 | 135.65 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - EUR Company profile
About Merck KGaA
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.
Equity composition
2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).
| Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com